GlassScriptPhysician profile
Delphine Tang
NPI 1588009195
$8,331.94
in general payments reported to CMS, 2019-2025
35 companies · $1,549 in 2025
The $1,549 reported for 2025 was more than what 79% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,340 · 2020: $1,515 · 2021: $184 · 2022: $982 · 2023: $1,235 · 2024: $1,527 · 2025: $1,549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,310.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,560.11 | 2019-2025 | Avvigo Guidance System, Mamba, Guidezilla |
| Medtronic Vascular, INC. | $1,228.17 | 2019-2020 | |
| Abbott Laboratories | $602.78 | 2019-2022 | |
| Abiomed | $536.96 | 2024-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $426.87 | 2019-2025 | Wainua |
| Novartis Pharmaceuticals Corporation | $299.10 | 2023-2025 | |
| Pfizer INC. | $295.76 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $283.27 | 2022-2025 | Verquvo |
| Amgen INC. | $240.43 | 2020-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $217.68 | 2022-2025 | Camzyos, Eliquis |
| Edwards Lifesciences Corporation | $193.70 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $184.87 | 2022-2025 | Jardiance |
| Cardiovascular Systems INC. | $143.84 | 2020 | |
| Janssen Pharmaceuticals, INC | $121.43 | 2022-2024 | Xarelto |
| Irhythm Technologies, INC. | $111.57 | 2023-2024 | Zio Xt Patch, Zio Monitor |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $99.47 | 2023 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $97.99 | 2021-2025 | Lifevest |
| Philips North America LLC | $95.57 | 2022-2024 | (Ck7) Extended Holter, (Ck4) Mcot |
| Novo Nordisk INC | $80.10 | 2022-2025 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $64.63 | 2022 | |
| Heartflow, INC. | $63.35 | 2024-2025 | |
| Daiichi Sankyo INC. | $62.37 | 2021-2023 | Injectafer |
| W. L. Gore & Associates, INC. | $61.94 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $48.56 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $32.93 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $24.80 | 2024 | |
| Genzyme Corporation | $22.88 | 2024 | |
| Exact Sciences Corporation | $19.91 | 2025 | Cologuard Collection Kit |
| Baxter Healthcare | $19.01 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Terumo Medical Corporation | $16.48 | 2020 | |
| Bridgebio Pharma, INC. | $16.36 | 2025 | Attruby |
| Kiniksa Pharmaceuticals, LTD. | $15.16 | 2023 | Arcalyst |
| Esperion Therapeutics, INC. | $14.98 | 2023 | Nexletol |
| Sanofi-Aventis U.S. LLC | $14.57 | 2022 | |
| Penumbra, INC. | $14.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Delphine Tang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.